212 related articles for article (PubMed ID: 16436331)
1. Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model.
Al-Majed AA; Sayed-Ahmed MM; Al-Yahya AA; Aleisa AM; Al-Rejaie SS; Al-Shabanah OA
Pharmacol Res; 2006 Mar; 53(3):278-86. PubMed ID: 16436331
[TBL] [Abstract][Full Text] [Related]
2. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
3. Carnitine deficiency aggravates cyclophosphamide-induced cardiotoxicity in rats.
Fatani AG; Darweesh AQ; Rizwan L; Aleisa AM; Al-Shabanah OA; Sayed-Ahmed MM
Chemotherapy; 2010; 56(1):71-81. PubMed ID: 20299794
[TBL] [Abstract][Full Text] [Related]
4. Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model.
Sayed-Ahmed MM; Eissa MA; Kenawy SA; Mostafa N; Calvani M; Osman AM
Chemotherapy; 2004 Oct; 50(4):162-70. PubMed ID: 15347908
[TBL] [Abstract][Full Text] [Related]
5. Carnitine deficiency and oxidative stress provoke cardiotoxicity in an ifosfamide-induced Fanconi Syndrome rat model.
Sayed-Ahmed MM; Darweesh AQ; Fatani AJ
Oxid Med Cell Longev; 2010; 3(4):266-74. PubMed ID: 20972373
[TBL] [Abstract][Full Text] [Related]
6. Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rats.
Al-Majed AA
Basic Clin Pharmacol Toxicol; 2007 Mar; 100(3):145-50. PubMed ID: 17309516
[TBL] [Abstract][Full Text] [Related]
7. Carnitine esters prevent oxidative stress damage and energy depletion following transient forebrain ischaemia in the rat hippocampus.
Al-Majed AA; Sayed-Ahmed MM; Al-Omar FA; Al-Yahya AA; Aleisa AM; Al-Shabanah OA
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):725-33. PubMed ID: 16895547
[TBL] [Abstract][Full Text] [Related]
8. Increased urinary losses of carnitine and decreased intramitochondrial coenzyme A in gentamicin-induced acute renal failure in rats.
Al-Shabanah OA; Aleisa AM; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Fatani AG; Sayed-Ahmed MM
Nephrol Dial Transplant; 2010 Jan; 25(1):69-76. PubMed ID: 19737869
[TBL] [Abstract][Full Text] [Related]
9. Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy.
Sayed-Ahmed MM; Salman TM; Gaballah HE; Abou El-Naga SA; Nicolai R; Calvani M
Pharmacol Res; 2001 Jun; 43(6):513-20. PubMed ID: 11419959
[TBL] [Abstract][Full Text] [Related]
10. Progression of cyclophosphamide-induced acute renal metabolic damage in carnitine-depleted rat model.
Sayed-Ahmed MM
Clin Exp Nephrol; 2010 Oct; 14(5):418-26. PubMed ID: 20652348
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiotoxic rat models.
Sayed-Ahmed MM; Aldelemy ML; Al-Shabanah OA; Hafez MM; Al-Hosaini KA; Al-Harbi NO; Al-Sharary SD; Al-Harbi MM
Cardiovasc Toxicol; 2014 Sep; 14(3):232-42. PubMed ID: 24469765
[TBL] [Abstract][Full Text] [Related]
12. Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats.
Al-Rejaie SS; Aleisa AM; Al-Yahya AA; Bakheet SA; Alsheikh A; Fatani AG; Al-Shabanah OA; Sayed-Ahmed MM
World J Gastroenterol; 2009 Mar; 15(11):1373-80. PubMed ID: 19294768
[TBL] [Abstract][Full Text] [Related]
13. L-Carnitine attenuates ifosfamide-induced carnitine deficiency and decreased intramitochondrial CoA-SH in rat kidney tissues.
Sayed-Ahmed MM
J Nephrol; 2011; 24(4):490-8. PubMed ID: 21404227
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies.
El-Awady el-SE; Moustafa YM; Abo-Elmatty DM; Radwan A
Eur J Pharmacol; 2011 Jan; 650(1):335-41. PubMed ID: 21034734
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model.
Sayed-Ahmed MM; Al-Shabanah OA; Hafez MM; Aleisa AM; Al-Rejaie SS
Eur J Pharmacol; 2010 Aug; 640(1-3):143-9. PubMed ID: 20470772
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy.
Yang XP; Samaja M; English E; Benatti P; Tarantola M; Cardace G; Motterlini R; Micheletti R; Bianchi G
J Cardiovasc Pharmacol; 1992 Jul; 20(1):88-98. PubMed ID: 1383636
[TBL] [Abstract][Full Text] [Related]
17. Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria.
Sayed-Ahmed MM; Shouman SA; Rezk BM; Khalifa MH; Osman AM; El-Merzabani MM
Pharmacol Res; 2000 Feb; 41(2):143-50. PubMed ID: 10623482
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
19. Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats.
Sayed-Ahmed MM; Nagi MN
Clin Exp Pharmacol Physiol; 2007; 34(5-6):399-405. PubMed ID: 17439407
[TBL] [Abstract][Full Text] [Related]
20. Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats.
Nagi MN; Al-Shabanah OA; Hafez MM; Sayed-Ahmed MM
J Biochem Mol Toxicol; 2011; 25(3):135-42. PubMed ID: 20957680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
